# Ernexa Therapeutics Inc.: Form 8-K, filed May 15, 2009

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2009-05-15
- Accepted by EDGAR: May 15, 2009, 12:16 ET
- Period: 2009-05-11
- Accession: 0001019687-09-001771
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000101968709001771/ntn_8k-051209.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000101968709001771/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000101968709001771/ntn_8k-051209.htm

Filed May 15, 2009.
Source: SEC EDGAR, the filing index for accession 0001019687-09-001771. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.
